Special Report on the American Legacy Foundation: As Legacy seeks new funding, critics fear symbiosis with Big Tobacco. Legacy, NCI, C-Change relationship could open door to industry influence, lawyer says.
Legacy CEO Cheryl Healton says foundation could serve as funder for research on “potentially reduced-exposure products.”
NCI-supported meeting included tobacco industry representatives in dialogue on ethics.
Also David Schwartz of Duke University to head NIEHS.
NCI funds nine centers for $14.9 million integrative biology program.
NIH awards 1,400 student loan repayment contracts.
Funding opportunities listed.
Trending Stories
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- GRAIL presses on with Galleri test despite missed primary endpoint in pivotal study
Where GRAIL sees signals of benefit in the subgroups, screening experts see signs of overdiagnosis - Vinay Prasad, oncologist and Twitter star, locked in debate over precision medicine
- Lawsuits brought against Tempus AI raise more questions than answers about DNA privacy in the AI era
- GRAIL’s Megan Hall: “I think we can be confident that there is clinical benefit to implementing this technology. And I think that’s really hard to argue with.”
Mainstream epidemiologists beg to differ - NCI’s Philip Castle on NHS-Galleri results: “I’m sorry that it didn’t work, but it keeps the national conversation going.”
Castle is “disappointed” by Galleri results but not discouraged by implications for MCDs
